Evommune EVMN
NYSE EVMN
$8.64 +0.80 (+10.14%)
As of: Nov 11, 2026 · 3:59 PM EST

Evommune (EVMN) Common Stock Issued (2024 - 2026)

Updated

Evommune (EVMN) reported Common Stock Issued of $674,000 for Q2 2026, compared with $4,000 a year earlier and down 99.4% from the prior quarter.

Analysis

Evommune (EVMN) Common Stock Issued (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Evommune's Common Stock Issued came in at $275.16 million; for FY2025, it came in at $157.29 million.

  • By year, Common Stock Issued came in at $13,000 in FY2024.
  • Five-year quarterly Common Stock Issued spans a low of $2,000 in Q1 2025 and a high of $157.28 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 743.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 247.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 87.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Evommune 285.17 Mn -352.34 Mn - 674,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 674,000.00
Mar 31, 2026 117.20 Mn
Dec 31, 2025 157.28 Mn
Jun 30, 2025 4,000.00
Mar 31, 2025 2,000.00
Dec 31, 2024 11,000.00
API Access

Evommune Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=EVMN&period=max&api_key=YOUR_API_KEY